Jiayang presents a "BUY" recommendation based on its recovery play at a cyclical low, with strong growth potential, strategic diversification, and AI-driven opportunities.
Share this post
Initial Report: EPAM System (NYSE: EPAM), 74…
Share this post
Jiayang presents a "BUY" recommendation based on its recovery play at a cyclical low, with strong growth potential, strategic diversification, and AI-driven opportunities.